CA1105566A - Implantable electrode - Google Patents
Implantable electrodeInfo
- Publication number
- CA1105566A CA1105566A CA320,554A CA320554A CA1105566A CA 1105566 A CA1105566 A CA 1105566A CA 320554 A CA320554 A CA 320554A CA 1105566 A CA1105566 A CA 1105566A
- Authority
- CA
- Canada
- Prior art keywords
- electrode
- implantable electrode
- electrode means
- filaments
- compress
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Landscapes
- Electrotherapy Devices (AREA)
Abstract
ABSTRACT OF THE DISCLOSURE
An improved implantable electrode for delivery of electrical stimulation pulses or signals to an organ such as the heart from an electrical pulse generator. The electrode is normally exposed to the organ to be stimulated and is, in turn, electrically, coupled to a conductive lead extending from the pulse generator, with the electrode being a body which substantially completely envelopes the lead. The electrode comprises a plurality of electri-cally conductive metallic filaments compressed together to form a generally fibrous body which may in certain instances be pliant or flexible in nature.
The filaments preferably have a mean, effective diameter less than about 100 microns and form from about 3% to 30% of the total volume of the fibrous member, and preferably from 5% to 20%. In one embodiment, the filaments are retained as a bundle within a metallic grid enclosure.
An improved implantable electrode for delivery of electrical stimulation pulses or signals to an organ such as the heart from an electrical pulse generator. The electrode is normally exposed to the organ to be stimulated and is, in turn, electrically, coupled to a conductive lead extending from the pulse generator, with the electrode being a body which substantially completely envelopes the lead. The electrode comprises a plurality of electri-cally conductive metallic filaments compressed together to form a generally fibrous body which may in certain instances be pliant or flexible in nature.
The filaments preferably have a mean, effective diameter less than about 100 microns and form from about 3% to 30% of the total volume of the fibrous member, and preferably from 5% to 20%. In one embodiment, the filaments are retained as a bundle within a metallic grid enclosure.
Description
BACKGROUND or TI~E INVENTION
The present invention relates generally to an improved implantable electrode for delivering electrical stimulation pulses to an organ, and more particularly to an improved implantable elec-trode means for delivery of electrical s-timulation pulses to the heart.
Heart pacer therapy and technology has expanded intensively, and with improvements available in batteries and circuitry, a need has now arise for improvement of the functional characteristics of the elec~rode. Recent improvements in batteries and a corresponding reduction of current consumption of the circuitry within the pulse generator have made it both desirable and necessary to improve electrode performance, particularly improvements relating to the current requirements of the electrode. Furthermore, most of the complications resulting from heart pacer therapy may be traced to the electrodes, and thus physical properties appear to also require improvement.
Studies have been conducted, and certain improvements in electrodes and leads have been made in the past. Specifically, metal fatigue has presented problems which may result in lead fractures.
Furthermore, improved lead sealing and electrode geometries have been developed, with one typical lead struc-ture being disclosed in United States Patent No. 4,033,355, July 5, 1977,Amundson, and entitled "Electrode Lead Assembly for Implantable Devices', assigned to applican-t herein.
Porous electrode structures have been known in the past, with the pores being formed in a solid structure and having a size of less than approximately lOO microns. Such structures have been of assistance, particularly in the compatibility of the porous structure to accommodate ingrowth into the channels of active heart tissue. Further improvements are available from the electrode structure of the present invention, with -these improvements including both electrical performance and accommodation of desirable heart tissue ingrowth. In electrical performance, improvements are found ....
.,,,, ~.
il~5566 ,articul.irly in -the reduction of polarization. Stimulation thresholds have been significantly reduced, with those of the present structure having been found to be as low as one third to one half of the requirements of conventional electrodes. The electrode of the present inven-tion consists of a filamentary member, wherein -lA-11~5~
the individual filaments may be compressed together to form a substantially solid body, and wherein the filaments preferably have a diameter of less than about 100 microns and form less than approximately 20% of the entire volume of the filamentary or fibrous electrode. In one embodiment, the individual fi laments may be compressed of compacted or compacted within a grid en~losure, with the individual elements forming the grid being slightly larger than the filaments forming the confined filamentary electrode, with the grid enclosure being adapted to confine, restrict, or otherwise retain the filamentary electrode i ntact.
Organ stimulation, particularly heart stimulation, may be described in terms of electrical field theory. Excitation is initiated by virtue of an electrical stimulus which exceeds a certain threshold level. The electrical field, therefore, may be characterized as a force being applied to the system.
Relating the field strength to the electrode structure, the maximum field strength is believed to be present at the surface of the electrode, with the magnitude of the field being generally inversely proportionally to the electrode size. In ordinary electrodes, the excitable tissue normally becomes spaced from the surface of the electrode by the growth of a barrier or layer of fibrotic material. Accordingly, the field strength must be related to that field which is available or effective at the interface which develops between the excitable tissue and the fibrotic tissue. Hence, any reduction in the formation or growth of fibrotic tissue should reasonably be calculated or increase the magnitude of the effective field at the excitable tissue boundary and thus increase the ultimate effectiveness of the electrode.
Furthermore, in normal heart pacers, particularly those of the demand/inhibit type or those which respond in synchrony to a natural heart signal, the electrode performs a sensing function as well as a stimulation function. The sensing impedance of the amplifiers typically used range in the order of 20,000 ohms, and any source impedance will, of course, be in series with the input impedance. The electrode of the present invention permits the source impedance to remain low, thereby enhancing the overall sensing capability of the electrode. As has been indicated, the polarization is exceptionally low, this being believed to be due to the large real surface area available for polari-zation considerations. However, it has also been found that the effective surface area of the structure is small for stimulation considerations. This appears to provide significant advantages for both operating parameters.
SUMMARY OF THE INVENTION
Turning now to the aspects of the present invention, the implantable electrode consists of a compressed or compacted bundle of metallic filaments or fibers, with the bundle being designed so as to substantially completely envelop the surface of the conductive lead which couples the pulse generator to the electrode. The individual fibers or filaments forming the fibrous member have a diameter of between about 10 microns and 100 microns, with the pre-ferred diameter being about 20 microns. The preferred filamentary diameter of 20 microns is due to the general match of the cell size with the filament size, with cell size being generally in the area of about 20 microns.
The solid filamentary material forms between about 3% to 30% of the volume of the member, with the lower ranges, such as approximately 5%
being preferred. The balance of the volume of the fibrous member is, of course, open. When less than about 3% of the volume is formed of the filamen-tary material, the structure appears to become overly porous, and when more than about 20% of the volume of the member is formed of the filamentary material, the finished structure appears to become generally quasi solid and may in some cases become somewhat less pliant in those de~es wherein this is a desired f eatu re.
As a result of this structural design, it has been found that substan-tially less energy is required for stimulation of the heart. A red~ction in polari-zation occurs, thereby further enhancing the performance of the electrode and reducing the energy required for constant and consistent organ stimulation over extendeci periods of time. Ingrowth occurs between the surrounding tissue and the electrode, thereby improving electrical response, and furthermore enhances the performance of the device for reducing the tendency toward dislodgement whiie also reducing abrasir,n.
Therefore, it is a primary object of the present invention to provide an improved implantable electrode structure which is particularly adapted for use in the electrical stimulation of an organ, such as the heart, with the el ectrode comprising a metal I ic fi I amentary bundle.
It is a further object of the present invention to provide an improved 11(~5566 implantable electrode means in the form of a fibrous tip member consisting of a filamentary probe which is arranged to be electrically coupled to a remotely disposed pulse generator, and being designed to substantially completely envelop the electrically conductive member which extends from the pulse genera-tor to the electrode.
It is yet a further object of the present invention to provide an improved implantable electrode means for use with heart pacemakers, wherein the electrode is formed as a bundle or compress of metallic fibers, and wherein the metal lic fibers have a diameter of less than about 100 microns and form between 3% and 30%.
A principal object is to provide an implantable electrode means for electrical stimulation of an organ from an electrical signal generator and including an electrically conductive lead member extending from said electrical signal generator to said implantable electrode means and having a surface in electrical contact with said implantable electrode means, said implantable electrode means comprising a plurality of electrically conductive metallic filaments retained together as a bundle to form a substantially solid body, with the filaments forming the bundle having a diameter of less than about 100 microns and forming between 3% and 30% of the volume of said fibrous member.
Other and further objects of the present invention will become apparent to those skilled in the art upon a study of the following specification, appended claims and accompanying drawings.
BRIEF DESCRIPTION OF THE DRAWINGS
Figure 1 is a flow diagram of a typical procedure which may be employed in the preparation of the implantable electrode means of the present invention;
Figure 2 is a side elevational view illustrating one typical embodi-ment of an implantabie electrode means of the present invention in combination with a typical pulse generator and conductive lead assembly;
Figure 3 is a sectional view on an enlarged scale taken through the diameter of one embodiment of the lead and electrode, and illustrating one m~n~ner in which the electrode may be secured to the conductive lead;
Figure 4 is a perspective view, partially broken away, and further illustrating the manner in which the implantable electrode of Figure 3 is coupled 1 1~5S~6 to the conductive lead;
Figure 5 is a sectional view taken along the line and in the direction of the arrows 5-S of Figure 3;
Figure 6 is a sectional view on an enlarged scale from Figure 2, and illustrating an alternate preferred embodiment of the lead and electrode, and illustrating the details of the alternate preferred embodiment;
Figure 7 is a perspective view, partially broken away, and further illustrating certain details of the embodiment of Figure 6, and the manner in which the electrode is coupled to the conductive lead; and Figure 8 is a sectional view taken along the line and in the direction of the arrows 8-8 of Figure 7.
DE~RIPTION OF THE_PREFERRED EMBODIMENTS
In accordance with one of the alternate preferred embodiments of the present invention, and with particular attention being directed to Figures
The present invention relates generally to an improved implantable electrode for delivering electrical stimulation pulses to an organ, and more particularly to an improved implantable elec-trode means for delivery of electrical s-timulation pulses to the heart.
Heart pacer therapy and technology has expanded intensively, and with improvements available in batteries and circuitry, a need has now arise for improvement of the functional characteristics of the elec~rode. Recent improvements in batteries and a corresponding reduction of current consumption of the circuitry within the pulse generator have made it both desirable and necessary to improve electrode performance, particularly improvements relating to the current requirements of the electrode. Furthermore, most of the complications resulting from heart pacer therapy may be traced to the electrodes, and thus physical properties appear to also require improvement.
Studies have been conducted, and certain improvements in electrodes and leads have been made in the past. Specifically, metal fatigue has presented problems which may result in lead fractures.
Furthermore, improved lead sealing and electrode geometries have been developed, with one typical lead struc-ture being disclosed in United States Patent No. 4,033,355, July 5, 1977,Amundson, and entitled "Electrode Lead Assembly for Implantable Devices', assigned to applican-t herein.
Porous electrode structures have been known in the past, with the pores being formed in a solid structure and having a size of less than approximately lOO microns. Such structures have been of assistance, particularly in the compatibility of the porous structure to accommodate ingrowth into the channels of active heart tissue. Further improvements are available from the electrode structure of the present invention, with -these improvements including both electrical performance and accommodation of desirable heart tissue ingrowth. In electrical performance, improvements are found ....
.,,,, ~.
il~5566 ,articul.irly in -the reduction of polarization. Stimulation thresholds have been significantly reduced, with those of the present structure having been found to be as low as one third to one half of the requirements of conventional electrodes. The electrode of the present inven-tion consists of a filamentary member, wherein -lA-11~5~
the individual filaments may be compressed together to form a substantially solid body, and wherein the filaments preferably have a diameter of less than about 100 microns and form less than approximately 20% of the entire volume of the filamentary or fibrous electrode. In one embodiment, the individual fi laments may be compressed of compacted or compacted within a grid en~losure, with the individual elements forming the grid being slightly larger than the filaments forming the confined filamentary electrode, with the grid enclosure being adapted to confine, restrict, or otherwise retain the filamentary electrode i ntact.
Organ stimulation, particularly heart stimulation, may be described in terms of electrical field theory. Excitation is initiated by virtue of an electrical stimulus which exceeds a certain threshold level. The electrical field, therefore, may be characterized as a force being applied to the system.
Relating the field strength to the electrode structure, the maximum field strength is believed to be present at the surface of the electrode, with the magnitude of the field being generally inversely proportionally to the electrode size. In ordinary electrodes, the excitable tissue normally becomes spaced from the surface of the electrode by the growth of a barrier or layer of fibrotic material. Accordingly, the field strength must be related to that field which is available or effective at the interface which develops between the excitable tissue and the fibrotic tissue. Hence, any reduction in the formation or growth of fibrotic tissue should reasonably be calculated or increase the magnitude of the effective field at the excitable tissue boundary and thus increase the ultimate effectiveness of the electrode.
Furthermore, in normal heart pacers, particularly those of the demand/inhibit type or those which respond in synchrony to a natural heart signal, the electrode performs a sensing function as well as a stimulation function. The sensing impedance of the amplifiers typically used range in the order of 20,000 ohms, and any source impedance will, of course, be in series with the input impedance. The electrode of the present invention permits the source impedance to remain low, thereby enhancing the overall sensing capability of the electrode. As has been indicated, the polarization is exceptionally low, this being believed to be due to the large real surface area available for polari-zation considerations. However, it has also been found that the effective surface area of the structure is small for stimulation considerations. This appears to provide significant advantages for both operating parameters.
SUMMARY OF THE INVENTION
Turning now to the aspects of the present invention, the implantable electrode consists of a compressed or compacted bundle of metallic filaments or fibers, with the bundle being designed so as to substantially completely envelop the surface of the conductive lead which couples the pulse generator to the electrode. The individual fibers or filaments forming the fibrous member have a diameter of between about 10 microns and 100 microns, with the pre-ferred diameter being about 20 microns. The preferred filamentary diameter of 20 microns is due to the general match of the cell size with the filament size, with cell size being generally in the area of about 20 microns.
The solid filamentary material forms between about 3% to 30% of the volume of the member, with the lower ranges, such as approximately 5%
being preferred. The balance of the volume of the fibrous member is, of course, open. When less than about 3% of the volume is formed of the filamen-tary material, the structure appears to become overly porous, and when more than about 20% of the volume of the member is formed of the filamentary material, the finished structure appears to become generally quasi solid and may in some cases become somewhat less pliant in those de~es wherein this is a desired f eatu re.
As a result of this structural design, it has been found that substan-tially less energy is required for stimulation of the heart. A red~ction in polari-zation occurs, thereby further enhancing the performance of the electrode and reducing the energy required for constant and consistent organ stimulation over extendeci periods of time. Ingrowth occurs between the surrounding tissue and the electrode, thereby improving electrical response, and furthermore enhances the performance of the device for reducing the tendency toward dislodgement whiie also reducing abrasir,n.
Therefore, it is a primary object of the present invention to provide an improved implantable electrode structure which is particularly adapted for use in the electrical stimulation of an organ, such as the heart, with the el ectrode comprising a metal I ic fi I amentary bundle.
It is a further object of the present invention to provide an improved 11(~5566 implantable electrode means in the form of a fibrous tip member consisting of a filamentary probe which is arranged to be electrically coupled to a remotely disposed pulse generator, and being designed to substantially completely envelop the electrically conductive member which extends from the pulse genera-tor to the electrode.
It is yet a further object of the present invention to provide an improved implantable electrode means for use with heart pacemakers, wherein the electrode is formed as a bundle or compress of metallic fibers, and wherein the metal lic fibers have a diameter of less than about 100 microns and form between 3% and 30%.
A principal object is to provide an implantable electrode means for electrical stimulation of an organ from an electrical signal generator and including an electrically conductive lead member extending from said electrical signal generator to said implantable electrode means and having a surface in electrical contact with said implantable electrode means, said implantable electrode means comprising a plurality of electrically conductive metallic filaments retained together as a bundle to form a substantially solid body, with the filaments forming the bundle having a diameter of less than about 100 microns and forming between 3% and 30% of the volume of said fibrous member.
Other and further objects of the present invention will become apparent to those skilled in the art upon a study of the following specification, appended claims and accompanying drawings.
BRIEF DESCRIPTION OF THE DRAWINGS
Figure 1 is a flow diagram of a typical procedure which may be employed in the preparation of the implantable electrode means of the present invention;
Figure 2 is a side elevational view illustrating one typical embodi-ment of an implantabie electrode means of the present invention in combination with a typical pulse generator and conductive lead assembly;
Figure 3 is a sectional view on an enlarged scale taken through the diameter of one embodiment of the lead and electrode, and illustrating one m~n~ner in which the electrode may be secured to the conductive lead;
Figure 4 is a perspective view, partially broken away, and further illustrating the manner in which the implantable electrode of Figure 3 is coupled 1 1~5S~6 to the conductive lead;
Figure 5 is a sectional view taken along the line and in the direction of the arrows 5-S of Figure 3;
Figure 6 is a sectional view on an enlarged scale from Figure 2, and illustrating an alternate preferred embodiment of the lead and electrode, and illustrating the details of the alternate preferred embodiment;
Figure 7 is a perspective view, partially broken away, and further illustrating certain details of the embodiment of Figure 6, and the manner in which the electrode is coupled to the conductive lead; and Figure 8 is a sectional view taken along the line and in the direction of the arrows 8-8 of Figure 7.
DE~RIPTION OF THE_PREFERRED EMBODIMENTS
In accordance with one of the alternate preferred embodiments of the present invention, and with particular attention being directed to Figures
2-5 of the drawings, it will be seen that the cardiac pacer assembly generally designated 10 includes a pulse generator with lead assembly 14 extending from the coupling zone or StatiOn 12 to the conductive electrode 15. Conductive electrode 15 is, of course, exposed and is generally in physical contact with the tissue to be stimulated, such as the heart muscle in the case of a cardiac pacer device. It will be understood that the configuration of the electrode as illustrated at 15 is merely one of many such designs, with the arrangement being appropriately adapted for either myocardial or epicardial type electrodes.
The arrangement of the device illustrated in Figure 2 is that of a unipolar cardiac pacer, and the assembly may be in the form of that assembly disclosed and claimed in United States Patent No. 3, 882,707. The circuitry for the pulse generator 1~ may be in the form of that circuitry disclosed in United States Patent No. 4,041,953.
It will be appreciated, of course, that bipolar leads may be prepared utilizing the features of the present invention. For purposes of comprehending the concept, however, a unipolar device is disclosed for simplicity.
Attention is now directed to Figures 3 and 4 of the drawings which illustrate the details of the lead assembly and the manner in which the implant-able electrode is secured thereto. Specifizally, as illustrated in Figure ~, the conductor system generally designated 20 includes a pair of parallel spans 21 ~1~`5566 ~nd 22, each of which is arranged in a helical pattern about a common axis. The coiled conductors have a uniform outer diameter, as is apparent in the structure shown in Figures 3 and 4. A pair of coaxially disposed tubular insulating sheaths 24 and 25 are illustra-ted to enclose the coiled conductors 21 and 22, it being appreciated, of course, that a single insulating sheath such as illustrated in the embodiment of Figures 6-8 inclusive may be employed as well. If desired, a double insulating sheath, such as is illustrated in Figure 3 may be employed, with such an arrangement being disclosed in United States Patent No. 4,0033,355.
In the embodiment illustrated in Figures 3-5 inclusive, electrode 15 is shown coupled electrically and mechanically to the outer circumference of the coil formed by helically wound conductors 21 and 22. In order to seal the lead assembly, a conductive cap member is provided, as shown at 26, with the filamentary metallic compress 27 being secured both electrically and mechanically to the outer surface thereof. It will be appreciated that other sealing techniques may be employed as desired.
Attention is now directed to Figures 6-8 of the drawings wherein the other of the alternate preferred embodiments is illustra-ted. Specifically, the conductor system, again generally designated 20, (this being designated with the same reference numeral as has been utilized in the corresponding component of Figure 3) includes a pair of parallel spans 21 and 22, each of which is arranged in a helical pattern ~out a common axis, as is true in the alternate embodiment of Figures 3 and ~. A tubular insulating sheath 30 encloses the coiled conductors 21 and 22.
In the embodiment illustrated in Figures 6-8 inclusive, electrode 31 is shown coupled electrically and mechanically to the outer circumference of the coil formed by helically wound conductors 21 and 22. ~lectrode 31 includes a bundle of filamentary fibers 32, enclosed within a metallic grid 33 of a composition similar to that of the fialements forming the enclosed bundle.
For materials of construction, it will be appreciated 1 lU5S66 .hat pl.atinum i.s preferred, with other substances being suitable such as, for example, Elgiloy, titanium, or platinum-iridium alloys. Elgiloy is the trade mark of Elgin Watch Company and is unique to a specific composition which is 40% cobalt, 20%
chromium, 15% nickel, 22.9% iron, 2% manganese and 0.1% carbon.
~oth Elgiloy and 90:10 platinum-iridium alloys are widely used as materials of construction for implantable electrodes.
.`~ 9~? - 6A-11~5566 , The material of construction for conductors 21 and 22 is preferably MP35N, nickel-chromium-cobalt alloy, this material being inert to body fluids, and possessing mechanical properties which include the requisite flexural characteristics, tensile strength, and resistance to fatigue.
PREPARATION OF_IMPLANTABLE ELECT_ODES
In order to prepare the implantable electrode, such as fibrous member 27, a bundle of metallic filaments of platinum are compressed together to form a substantially solid body, and prepared for sintering. The compress is placed within~a suitable cavity or chamber, and heated to a temperature of 1500 C. for a period of about 2 hours. This raises the temperature of the metal sufficiently so as to provide substantial VapOr pressure for the platinum, and thus form the desired cohesive compress. The diameter of the individual filaments is, in this example, 18 microns, although filament diameters ranging from between about 10 microns and 100 microns may be suitably employed. As a further consideration, the volumetric parameters provide for the structure to b~preferably 95 percent open, with the metallic filaments forming the balance of 5% of the volume. It has been found, however, that up to approxi-mately 20% of the volume may be metallic filaments.
In order to prepare the implantable electrode of the embodiment illustrated in Figures 6-8, a bundle of metallic filaments of platinum are com-pressed together to form a substantially solid bundle, and the bundle is then placed w jthin the confines of the grid enclosure. Specifically, the grid enclosure is formed of the same material as the metallic filaments, and normally has a reticulated pattern of l50 x 150 filaments per inch, with each filament having a diameter of 0. 001 inches. In certain instances, a grid having some-what larger diameter lines may be employed, such as up to approximately 0.002 inches, with one such grid having filament 0.0017 inches in diameter being commercially available. ln this embodiment, the bundle is approximately 90%
open, with the metallic filaments forming the balance of 10% of the volume.
Stated another way, the material is 10% dense. The individual filaments form-ing the bundle have a diameter of from between about 10 microns and 100 microns although in the specific example, the filaments have a diameter of 20 microns.
In order to form a solid compress or bundle, the filaments within the grid enclosure are heated to a temperature of 1500C. for a period of about 2 hours to permit sintering to occur.
As has been indicated, the metallic filament structure of the present invention contributes to a reduction of fibrosis. The reduction is believed due to the utilization of the small diameter metallic filament, together with the provision of permitting approximately 80% or more of the structure to be open. The organ being stimulated provides certain ingrowth into the electrode element, with the ingrowth contributing to a red~ction in abrasion, and a more uniform electrical response and function. Therefore, the active heart tissue is disposed more closely adjacent to the surface portions of the electrode which generate the field which performs the actual stimulation.
Furthermore, polarization during stimulation is substantially reduced, with measurements indicating that polarization is almost eliminated for most normal cardiac pacer functions. In addition, the sensing function is formed effectively by the structure of the present invention.
While the utilization of a non-woven filamentary mass is contem-plated and discussed herein, it will also be appreciated that a woven or knitted pattern may also be employed to form the overall structure. In such an arrangement, the parameters of filament size and volume considerations remain as set forth above.
While various techniques may be employed to bond the electrode structure to the conductive leads, it has been found that diffusion bonding is generally preferred. This is particularly desirable or applicable to the structure illustrated in Figures 6-8.
The arrangement of the device illustrated in Figure 2 is that of a unipolar cardiac pacer, and the assembly may be in the form of that assembly disclosed and claimed in United States Patent No. 3, 882,707. The circuitry for the pulse generator 1~ may be in the form of that circuitry disclosed in United States Patent No. 4,041,953.
It will be appreciated, of course, that bipolar leads may be prepared utilizing the features of the present invention. For purposes of comprehending the concept, however, a unipolar device is disclosed for simplicity.
Attention is now directed to Figures 3 and 4 of the drawings which illustrate the details of the lead assembly and the manner in which the implant-able electrode is secured thereto. Specifizally, as illustrated in Figure ~, the conductor system generally designated 20 includes a pair of parallel spans 21 ~1~`5566 ~nd 22, each of which is arranged in a helical pattern about a common axis. The coiled conductors have a uniform outer diameter, as is apparent in the structure shown in Figures 3 and 4. A pair of coaxially disposed tubular insulating sheaths 24 and 25 are illustra-ted to enclose the coiled conductors 21 and 22, it being appreciated, of course, that a single insulating sheath such as illustrated in the embodiment of Figures 6-8 inclusive may be employed as well. If desired, a double insulating sheath, such as is illustrated in Figure 3 may be employed, with such an arrangement being disclosed in United States Patent No. 4,0033,355.
In the embodiment illustrated in Figures 3-5 inclusive, electrode 15 is shown coupled electrically and mechanically to the outer circumference of the coil formed by helically wound conductors 21 and 22. In order to seal the lead assembly, a conductive cap member is provided, as shown at 26, with the filamentary metallic compress 27 being secured both electrically and mechanically to the outer surface thereof. It will be appreciated that other sealing techniques may be employed as desired.
Attention is now directed to Figures 6-8 of the drawings wherein the other of the alternate preferred embodiments is illustra-ted. Specifically, the conductor system, again generally designated 20, (this being designated with the same reference numeral as has been utilized in the corresponding component of Figure 3) includes a pair of parallel spans 21 and 22, each of which is arranged in a helical pattern ~out a common axis, as is true in the alternate embodiment of Figures 3 and ~. A tubular insulating sheath 30 encloses the coiled conductors 21 and 22.
In the embodiment illustrated in Figures 6-8 inclusive, electrode 31 is shown coupled electrically and mechanically to the outer circumference of the coil formed by helically wound conductors 21 and 22. ~lectrode 31 includes a bundle of filamentary fibers 32, enclosed within a metallic grid 33 of a composition similar to that of the fialements forming the enclosed bundle.
For materials of construction, it will be appreciated 1 lU5S66 .hat pl.atinum i.s preferred, with other substances being suitable such as, for example, Elgiloy, titanium, or platinum-iridium alloys. Elgiloy is the trade mark of Elgin Watch Company and is unique to a specific composition which is 40% cobalt, 20%
chromium, 15% nickel, 22.9% iron, 2% manganese and 0.1% carbon.
~oth Elgiloy and 90:10 platinum-iridium alloys are widely used as materials of construction for implantable electrodes.
.`~ 9~? - 6A-11~5566 , The material of construction for conductors 21 and 22 is preferably MP35N, nickel-chromium-cobalt alloy, this material being inert to body fluids, and possessing mechanical properties which include the requisite flexural characteristics, tensile strength, and resistance to fatigue.
PREPARATION OF_IMPLANTABLE ELECT_ODES
In order to prepare the implantable electrode, such as fibrous member 27, a bundle of metallic filaments of platinum are compressed together to form a substantially solid body, and prepared for sintering. The compress is placed within~a suitable cavity or chamber, and heated to a temperature of 1500 C. for a period of about 2 hours. This raises the temperature of the metal sufficiently so as to provide substantial VapOr pressure for the platinum, and thus form the desired cohesive compress. The diameter of the individual filaments is, in this example, 18 microns, although filament diameters ranging from between about 10 microns and 100 microns may be suitably employed. As a further consideration, the volumetric parameters provide for the structure to b~preferably 95 percent open, with the metallic filaments forming the balance of 5% of the volume. It has been found, however, that up to approxi-mately 20% of the volume may be metallic filaments.
In order to prepare the implantable electrode of the embodiment illustrated in Figures 6-8, a bundle of metallic filaments of platinum are com-pressed together to form a substantially solid bundle, and the bundle is then placed w jthin the confines of the grid enclosure. Specifically, the grid enclosure is formed of the same material as the metallic filaments, and normally has a reticulated pattern of l50 x 150 filaments per inch, with each filament having a diameter of 0. 001 inches. In certain instances, a grid having some-what larger diameter lines may be employed, such as up to approximately 0.002 inches, with one such grid having filament 0.0017 inches in diameter being commercially available. ln this embodiment, the bundle is approximately 90%
open, with the metallic filaments forming the balance of 10% of the volume.
Stated another way, the material is 10% dense. The individual filaments form-ing the bundle have a diameter of from between about 10 microns and 100 microns although in the specific example, the filaments have a diameter of 20 microns.
In order to form a solid compress or bundle, the filaments within the grid enclosure are heated to a temperature of 1500C. for a period of about 2 hours to permit sintering to occur.
As has been indicated, the metallic filament structure of the present invention contributes to a reduction of fibrosis. The reduction is believed due to the utilization of the small diameter metallic filament, together with the provision of permitting approximately 80% or more of the structure to be open. The organ being stimulated provides certain ingrowth into the electrode element, with the ingrowth contributing to a red~ction in abrasion, and a more uniform electrical response and function. Therefore, the active heart tissue is disposed more closely adjacent to the surface portions of the electrode which generate the field which performs the actual stimulation.
Furthermore, polarization during stimulation is substantially reduced, with measurements indicating that polarization is almost eliminated for most normal cardiac pacer functions. In addition, the sensing function is formed effectively by the structure of the present invention.
While the utilization of a non-woven filamentary mass is contem-plated and discussed herein, it will also be appreciated that a woven or knitted pattern may also be employed to form the overall structure. In such an arrangement, the parameters of filament size and volume considerations remain as set forth above.
While various techniques may be employed to bond the electrode structure to the conductive leads, it has been found that diffusion bonding is generally preferred. This is particularly desirable or applicable to the structure illustrated in Figures 6-8.
Claims (7)
1. An implantable electrode means for electrical stimu-lation of an organ from an electrical signal generator and including an electrically conductive lead member extending from said electrical signal generator to said implantable electrode means and having a surface in electrical contact with said implantable electrode means, said implantable electrode means comprising a plurality of electri-cally conductive metallic filaments retained together as a bundle to form a compress, with the filaments forming the compress having a diameter of less than about 100 microns and forming between 3%
and 30% of the volume of said compress.
and 30% of the volume of said compress.
2. The implantable electrode means as defined in claim 1 being particularly characterized in that said filamentary compress is retained within a grid enclosure.
3. The implantable electrode means as defined in claim 2 being particularly characterized in that said grid enclosure is formed of the same metallic substance as said metallic filaments.
4. The implantable electrode means as defined in claim 1 being particularly characterized in that said filaments form approximately 5% of the volume of said filamentary compress.
5. The implantable electrode means as defined in claim 1 being particularly characterized in that said metallic filaments consist of a metal selected from the group consisting of platinum, Elgiloy, titanium, and platinum-iridium.
6. The implantable electrode means as defined in claim 1 being particularly characterized in that said metallic filaments consist of sintered platinum.
7. The implantable electrode means as defined in claim 1 being particularly characterized in that said filamentary compress is coupled to said electrically conductive lead member by diffusion bonding.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA320,554A CA1105566A (en) | 1979-01-31 | 1979-01-31 | Implantable electrode |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA320,554A CA1105566A (en) | 1979-01-31 | 1979-01-31 | Implantable electrode |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA1105566A true CA1105566A (en) | 1981-07-21 |
Family
ID=4113426
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA320,554A Expired CA1105566A (en) | 1979-01-31 | 1979-01-31 | Implantable electrode |
Country Status (1)
| Country | Link |
|---|---|
| CA (1) | CA1105566A (en) |
-
1979
- 1979-01-31 CA CA320,554A patent/CA1105566A/en not_active Expired
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4156429A (en) | Implantable electrode | |
| US5020544A (en) | Low energy defibrillation electrode | |
| US4679572A (en) | Low threshold cardiac pacing electrodes | |
| AU673038B2 (en) | Substrate for a sintered electrode | |
| US5074313A (en) | Porous electrode with enhanced reactive surface | |
| US5330521A (en) | Low resistance implantable electrical leads | |
| Furman et al. | Decreasing electrode size and increasing efficiency of cardiac stimulation | |
| US7904180B2 (en) | Capacitive medical electrode | |
| US4352360A (en) | Semiconductor low-threshhold electrode | |
| EP0573275B1 (en) | High efficiency tissue stimulating and signal sensing electrode | |
| US6546292B1 (en) | High impedance, low polarization cardiac electrode | |
| US4919135A (en) | Triaxial electrode | |
| CA1066364A (en) | Patient stimulating electrode | |
| US5683444A (en) | Composite electrode | |
| WO2002028476A2 (en) | Biostable small french lead | |
| JPS5812661A (en) | Porous electrode for pace-maker and production thereof | |
| EP0660735A1 (en) | Implantable defibrillation system | |
| US4534366A (en) | Carbon fiber pacing electrode | |
| US5466247A (en) | Subcutaneous electrode for stimulating skeletal musculature | |
| US7831312B2 (en) | Floating adapter for use with auxiliary lead assembly | |
| Irnich | Comparison of pacing electrodes of different shape and material—recommendations | |
| CA1105566A (en) | Implantable electrode | |
| US20060122681A1 (en) | Automatic capture pacing lead | |
| Joglar et al. | Initial experience with a high-impedance tined endocardial pacemaker lead: Evidence for increased lead failure | |
| Djordjevic et al. | Target Lead—Low Threshold Electrode: Une Électrode à Seuil Bas: La “Target” |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MKEX | Expiry |